Canaccord Genuity on Life Sciences/Biotechnology: Selected Small Cap Biotech Roundup

Canaccord analyst said, "Immunogen (Nasdaq: IMGN) (Buy-rated) Investment recommendation: Although ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE